SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-18-021734
Filing Date
2018-06-22
Accepted
2018-06-22 09:40:30
Documents
1
Period of Report
2018-06-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3754
  Complete submission text file 0001127602-18-021734.txt   5192
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 C/O ARALEZ PHARMACEUTICALS INC. MISSISSAUGA A6 L5N 0E4
Business Address
LEE KENNETH B JR (Reporting) CIK: 0001208570 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 18913300